U.S., Nov. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07223892) titled 'Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds' on Oct. 23.
Brief Summary: Chronic wounds constitute a significant global health burden, affecting millions of individuals and contributing to increased morbidity, diminished quality of life, and rising healthcare costs. These wounds are characterized by delayed healing and are often associated with complex etiologies and prolonged treatment courses. This study aims to evaluate the clinical efficacy and cost-effectiveness of Carbonlife amniotic tissue products (ATPs) compared to standard wound care in the management of chronic wounds. A prospective, co...